查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1412844

长效避孕药市场：按类型、产品、应用和最终用途分类 - 2024-2030 年全球预测

Long-acting Contraception Market by Type (Long-Acting Contraceptives, Short-Acting Contraceptives), Product (Injectables, Intrauterine Devices, Subdermal Implants), Application, End-use - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 191 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计2023年资避孕药市场规模为34.2亿美元，2024年达36.8亿美元，2030年预计将达55.2亿美元，复合年增长率为7.06%。

长效避孕药的全球市场

主要市场统计
基准年[2023] 34.2亿美元
预测年份 [2024] 36.8亿美元
预测年份 [2030] 55.2亿美元
复合年增长率（%） 7.06%
长效避孕药市场-IMG1

FPNV定位矩阵

FPNV定位矩阵对于评估长效避孕药市场至关重要。我们检视与业务策略和产品满意度相关的关键指标，以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出资讯的决策。根据评估，供应商被分为四个成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市场占有率分析

市场占有率分析是一种综合工具，可以对长效避孕药市场供应商的现状进行深入而详细的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献，以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外，该分析还提供了对该行业竞争特征的宝贵考察，包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。这种详细程度的提高使供应商能够做出更资讯的决策并制定有效的策略，从而在市场上获得竞争优势。

该报告对以下几个方面提供了宝贵的见解：

1-市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2-市场开拓：我们深入研究利润丰厚的新兴市场，并分析它们在成熟细分市场中的渗透率。

3- 市场多元化：提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。

4-竞争力评估与资讯：对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况、製造能力等进行全面评估。

5- 产品开发与创新：提供对未来技术、研发活动和突破性产品开发的见解。

本报告解决了以下关键问题：

1-长效避孕药市场的市场规模与预测是多少？

2-长效避孕药市场预测期间需要考虑投资的产品、细分市场、应用和领域有哪些？

3-长效避孕药市场的技术趋势和法律规范是什么？

4-长效避孕药市场主要供应商的市场占有率是多少？

5-进入长效避孕药市场合适的型态和策略手段是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 男性和女性则较多采用长期避孕措施
      • 增加公共资助的计划生育服务
    • 抑制因素
      • 长期避孕的副作用
    • 机会
      • 介绍技术先进的长期避孕方法
      • 政府对 LTC 的大力支持
    • 任务
      • 对有限核准产品的担忧
  • 市场区隔分析
  • 市场趋势分析
  • 高通膨的累积效应
  • 波特五力分析
  • 价值炼和关键路径分析
  • 法律规范

第六章长效避孕药市场：依类型

  • 长效避孕药
  • 短效避孕药

第七章 长效避孕药市场：副产品

  • 注射
  • 子宫内避孕器
  • 皮下植入

第八章长效避孕药市场：依应用分类

  • 避孕
  • HIV
  • 思觉失调症

第九章长效避孕药市场：依最终用途分类

  • 药局
  • 电子商务
  • 医院

第十章美洲长效避孕药市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太长效避孕药市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章欧洲、中东和非洲长效避孕药市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争形势

  • FPNV定位矩阵
  • 市场占有率分析：主要企业
  • 主要企业竞争情境分析

第14章竞争产品组合

  • 主要公司简介
    • AbbVie Inc.
    • Bayer AG
    • DKT International
    • HRA Pharma SAS by Perrigo Company plc
    • Merck & Co., Inc.
    • Meril Life Sciences Pvt. Ltd.
    • Mona Lisa NV
    • OCON Healthcare
    • Pfizer Inc.
    • Pregna International Limited
    • Prosan International BV
    • SMB Corporation of India
    • Teva Pharmaceuticals Industries Ltd.
    • The Cooper Companies, Inc.
    • Viatris Inc.
  • 主要产品系列

第十五章附录

  • 讨论指南
  • 关于许可证和定价
Product Code: MRR-563BF1FD02DB

[191 Pages Report] The Long-acting Contraception Market size was estimated at USD 3.42 billion in 2023 and expected to reach USD 3.68 billion in 2024, at a CAGR 7.06% to reach USD 5.52 billion by 2030.

Global Long-acting Contraception Market

KEY MARKET STATISTICS
Base Year [2023] USD 3.42 billion
Estimated Year [2024] USD 3.68 billion
Forecast Year [2030] USD 5.52 billion
CAGR (%) 7.06%
Long-acting Contraception Market - IMG1

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Long-acting Contraception Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Long-acting Contraception Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Long-acting Contraception Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Bayer AG, DKT International, HRA Pharma SAS by Perrigo Company plc, Merck & Co., Inc., Meril Life Sciences Pvt. Ltd., Mona Lisa N.V., OCON Healthcare, Pfizer Inc., Pregna International Limited, Prosan International B.V., SMB Corporation of India, Teva Pharmaceuticals Industries Ltd., The Cooper Companies, Inc., and Viatris Inc..

Market Segmentation & Coverage

This research report categorizes the Long-acting Contraception Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Type
    • Long-Acting Contraceptives
    • Short-Acting Contraceptives
  • Product
    • Injectables
    • Intrauterine Devices
    • Subdermal Implants
  • Application
    • Contraception
    • HIV
    • Schizophrenia
  • End-use
    • Drug Store
    • E-Commerce
    • Hospital
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Long-acting Contraception Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Long-acting Contraception Market?

3. What are the technology trends and regulatory frameworks in the Long-acting Contraception Market?

4. What is the market share of the leading vendors in the Long-acting Contraception Market?

5. Which modes and strategic moves are suitable for entering the Long-acting Contraception Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Long-acting Contraception Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising adoption of long term contraception among male and female
      • 5.1.1.2. Rising publicly funded family planning services
    • 5.1.2. Restraints
      • 5.1.2.1. Associated side effects of long term contraception
    • 5.1.3. Opportunities
      • 5.1.3.1. Introduction of technically advanced long term contraception methods
      • 5.1.3.2. Strong government support for LTC
    • 5.1.4. Challenges
      • 5.1.4.1. Concern regarding limited approved products
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Long-acting Contraception Market, by Type

  • 6.1. Introduction
  • 6.2. Long-Acting Contraceptives
  • 6.3. Short-Acting Contraceptives

7. Long-acting Contraception Market, by Product

  • 7.1. Introduction
  • 7.2. Injectables
  • 7.3. Intrauterine Devices
  • 7.4. Subdermal Implants

8. Long-acting Contraception Market, by Application

  • 8.1. Introduction
  • 8.2. Contraception
  • 8.3. HIV
  • 8.4. Schizophrenia

9. Long-acting Contraception Market, by End-use

  • 9.1. Introduction
  • 9.2. Drug Store
  • 9.3. E-Commerce
  • 9.4. Hospital

10. Americas Long-acting Contraception Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Long-acting Contraception Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Long-acting Contraception Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. FPNV Positioning Matrix
  • 13.2. Market Share Analysis, By Key Player
  • 13.3. Competitive Scenario Analysis, By Key Player

14. Competitive Portfolio

  • 14.1. Key Company Profiles
    • 14.1.1. AbbVie Inc.
    • 14.1.2. Bayer AG
    • 14.1.3. DKT International
    • 14.1.4. HRA Pharma SAS by Perrigo Company plc
    • 14.1.5. Merck & Co., Inc.
    • 14.1.6. Meril Life Sciences Pvt. Ltd.
    • 14.1.7. Mona Lisa N.V.
    • 14.1.8. OCON Healthcare
    • 14.1.9. Pfizer Inc.
    • 14.1.10. Pregna International Limited
    • 14.1.11. Prosan International B.V.
    • 14.1.12. SMB Corporation of India
    • 14.1.13. Teva Pharmaceuticals Industries Ltd.
    • 14.1.14. The Cooper Companies, Inc.
    • 14.1.15. Viatris Inc.
  • 14.2. Key Product Portfolio

15. Appendix

  • 15.1. Discussion Guide
  • 15.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. LONG-ACTING CONTRACEPTION MARKET RESEARCH PROCESS
  • FIGURE 2. LONG-ACTING CONTRACEPTION MARKET SIZE, 2023 VS 2030
  • FIGURE 3. LONG-ACTING CONTRACEPTION MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. LONG-ACTING CONTRACEPTION MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. LONG-ACTING CONTRACEPTION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. LONG-ACTING CONTRACEPTION MARKET DYNAMICS
  • FIGURE 7. LONG-ACTING CONTRACEPTION MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 8. LONG-ACTING CONTRACEPTION MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 10. LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. LONG-ACTING CONTRACEPTION MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 12. LONG-ACTING CONTRACEPTION MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. LONG-ACTING CONTRACEPTION MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
  • FIGURE 14. LONG-ACTING CONTRACEPTION MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS LONG-ACTING CONTRACEPTION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. AMERICAS LONG-ACTING CONTRACEPTION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES LONG-ACTING CONTRACEPTION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 18. UNITED STATES LONG-ACTING CONTRACEPTION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. ASIA-PACIFIC LONG-ACTING CONTRACEPTION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC LONG-ACTING CONTRACEPTION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA LONG-ACTING CONTRACEPTION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA LONG-ACTING CONTRACEPTION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. LONG-ACTING CONTRACEPTION MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 24. LONG-ACTING CONTRACEPTION MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. LONG-ACTING CONTRACEPTION MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. LONG-ACTING CONTRACEPTION MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. LONG-ACTING CONTRACEPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 6. LONG-ACTING CONTRACEPTION MARKET SIZE, BY LONG-ACTING CONTRACEPTIVES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. LONG-ACTING CONTRACEPTION MARKET SIZE, BY SHORT-ACTING CONTRACEPTIVES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 9. LONG-ACTING CONTRACEPTION MARKET SIZE, BY INJECTABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. LONG-ACTING CONTRACEPTION MARKET SIZE, BY INTRAUTERINE DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. LONG-ACTING CONTRACEPTION MARKET SIZE, BY SUBDERMAL IMPLANTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. LONG-ACTING CONTRACEPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 13. LONG-ACTING CONTRACEPTION MARKET SIZE, BY CONTRACEPTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. LONG-ACTING CONTRACEPTION MARKET SIZE, BY HIV, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. LONG-ACTING CONTRACEPTION MARKET SIZE, BY SCHIZOPHRENIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. LONG-ACTING CONTRACEPTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 17. LONG-ACTING CONTRACEPTION MARKET SIZE, BY DRUG STORE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. LONG-ACTING CONTRACEPTION MARKET SIZE, BY E-COMMERCE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. LONG-ACTING CONTRACEPTION MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS LONG-ACTING CONTRACEPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS LONG-ACTING CONTRACEPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS LONG-ACTING CONTRACEPTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS LONG-ACTING CONTRACEPTION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA LONG-ACTING CONTRACEPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA LONG-ACTING CONTRACEPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA LONG-ACTING CONTRACEPTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 29. BRAZIL LONG-ACTING CONTRACEPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL LONG-ACTING CONTRACEPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL LONG-ACTING CONTRACEPTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 33. CANADA LONG-ACTING CONTRACEPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA LONG-ACTING CONTRACEPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA LONG-ACTING CONTRACEPTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 37. MEXICO LONG-ACTING CONTRACEPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. MEXICO LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO LONG-ACTING CONTRACEPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO LONG-ACTING CONTRACEPTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 41. UNITED STATES LONG-ACTING CONTRACEPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES LONG-ACTING CONTRACEPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES LONG-ACTING CONTRACEPTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES LONG-ACTING CONTRACEPTION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 46. ASIA-PACIFIC LONG-ACTING CONTRACEPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. ASIA-PACIFIC LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC LONG-ACTING CONTRACEPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC LONG-ACTING CONTRACEPTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC LONG-ACTING CONTRACEPTION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 51. AUSTRALIA LONG-ACTING CONTRACEPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. AUSTRALIA LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 53. AUSTRALIA LONG-ACTING CONTRACEPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. AUSTRALIA LONG-ACTING CONTRACEPTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 55. CHINA LONG-ACTING CONTRACEPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. CHINA LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 57. CHINA LONG-ACTING CONTRACEPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. CHINA LONG-ACTING CONTRACEPTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 59. INDIA LONG-ACTING CONTRACEPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. INDIA LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 61. INDIA LONG-ACTING CONTRACEPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. INDIA LONG-ACTING CONTRACEPTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 63. INDONESIA LONG-ACTING CONTRACEPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. INDONESIA LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 65. INDONESIA LONG-ACTING CONTRACEPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. INDONESIA LONG-ACTING CONTRACEPTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 67. JAPAN LONG-ACTING CONTRACEPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. JAPAN LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 69. JAPAN LONG-ACTING CONTRACEPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. JAPAN LONG-ACTING CONTRACEPTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 71. MALAYSIA LONG-ACTING CONTRACEPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. MALAYSIA LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 73. MALAYSIA LONG-ACTING CONTRACEPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. MALAYSIA LONG-ACTING CONTRACEPTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 75. PHILIPPINES LONG-ACTING CONTRACEPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. PHILIPPINES LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 77. PHILIPPINES LONG-ACTING CONTRACEPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. PHILIPPINES LONG-ACTING CONTRACEPTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 79. SINGAPORE LONG-ACTING CONTRACEPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. SINGAPORE LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 81. SINGAPORE LONG-ACTING CONTRACEPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. SINGAPORE LONG-ACTING CONTRACEPTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 83. SOUTH KOREA LONG-ACTING CONTRACEPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. SOUTH KOREA LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH KOREA LONG-ACTING CONTRACEPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH KOREA LONG-ACTING CONTRACEPTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 87. TAIWAN LONG-ACTING CONTRACEPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. TAIWAN LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 89. TAIWAN LONG-ACTING CONTRACEPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. TAIWAN LONG-ACTING CONTRACEPTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 91. THAILAND LONG-ACTING CONTRACEPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. THAILAND LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 93. THAILAND LONG-ACTING CONTRACEPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. THAILAND LONG-ACTING CONTRACEPTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 95. VIETNAM LONG-ACTING CONTRACEPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. VIETNAM LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 97. VIETNAM LONG-ACTING CONTRACEPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. VIETNAM LONG-ACTING CONTRACEPTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 99. EUROPE, MIDDLE EAST & AFRICA LONG-ACTING CONTRACEPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA LONG-ACTING CONTRACEPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA LONG-ACTING CONTRACEPTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA LONG-ACTING CONTRACEPTION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 104. DENMARK LONG-ACTING CONTRACEPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. DENMARK LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 106. DENMARK LONG-ACTING CONTRACEPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. DENMARK LONG-ACTING CONTRACEPTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 108. EGYPT LONG-ACTING CONTRACEPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. EGYPT LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 110. EGYPT LONG-ACTING CONTRACEPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. EGYPT LONG-ACTING CONTRACEPTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 112. FINLAND LONG-ACTING CONTRACEPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. FINLAND LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 114. FINLAND LONG-ACTING CONTRACEPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. FINLAND LONG-ACTING CONTRACEPTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 116. FRANCE LONG-ACTING CONTRACEPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. FRANCE LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 118. FRANCE LONG-ACTING CONTRACEPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. FRANCE LONG-ACTING CONTRACEPTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 120. GERMANY LONG-ACTING CONTRACEPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. GERMANY LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 122. GERMANY LONG-ACTING CONTRACEPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. GERMANY LONG-ACTING CONTRACEPTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 124. ISRAEL LONG-ACTING CONTRACEPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. ISRAEL LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 126. ISRAEL LONG-ACTING CONTRACEPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. ISRAEL LONG-ACTING CONTRACEPTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 128. ITALY LONG-ACTING CONTRACEPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. ITALY LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 130. ITALY LONG-ACTING CONTRACEPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. ITALY LONG-ACTING CONTRACEPTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 132. NETHERLANDS LONG-ACTING CONTRACEPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. NETHERLANDS LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 134. NETHERLANDS LONG-ACTING CONTRACEPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. NETHERLANDS LONG-ACTING CONTRACEPTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 136. NIGERIA LONG-ACTING CONTRACEPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. NIGERIA LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 138. NIGERIA LONG-ACTING CONTRACEPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. NIGERIA LONG-ACTING CONTRACEPTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 140. NORWAY LONG-ACTING CONTRACEPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. NORWAY LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 142. NORWAY LONG-ACTING CONTRACEPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. NORWAY LONG-ACTING CONTRACEPTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 144. POLAND LONG-ACTING CONTRACEPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. POLAND LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 146. POLAND LONG-ACTING CONTRACEPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 147. POLAND LONG-ACTING CONTRACEPTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 148. QATAR LONG-ACTING CONTRACEPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 149. QATAR LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 150. QATAR LONG-ACTING CONTRACEPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 151. QATAR LONG-ACTING CONTRACEPTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 152. RUSSIA LONG-ACTING CONTRACEPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 153. RUSSIA LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 154. RUSSIA LONG-ACTING CONTRACEPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 155. RUSSIA LONG-ACTING CONTRACEPTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 156. SAUDI ARABIA LONG-ACTING CONTRACEPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 157. SAUDI ARABIA LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 158. SAUDI ARABIA LONG-ACTING CONTRACEPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 159. SAUDI ARABIA LONG-ACTING CONTRACEPTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 160. SOUTH AFRICA LONG-ACTING CONTRACEPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 161. SOUTH AFRICA LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 162. SOUTH AFRICA LONG-ACTING CONTRACEPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH AFRICA LONG-ACTING CONTRACEPTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 164. SPAIN LONG-ACTING CONTRACEPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 165. SPAIN LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 166. SPAIN LONG-ACTING CONTRACEPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 167. SPAIN LONG-ACTING CONTRACEPTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 168. SWEDEN LONG-ACTING CONTRACEPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 169. SWEDEN LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 170. SWEDEN LONG-ACTING CONTRACEPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 171. SWEDEN LONG-ACTING CONTRACEPTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 172. SWITZERLAND LONG-ACTING CONTRACEPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 173. SWITZERLAND LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 174. SWITZERLAND LONG-ACTING CONTRACEPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 175. SWITZERLAND LONG-ACTING CONTRACEPTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 176. TURKEY LONG-ACTING CONTRACEPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 177. TURKEY LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 178. TURKEY LONG-ACTING CONTRACEPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 179. TURKEY LONG-ACTING CONTRACEPTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 180. UNITED ARAB EMIRATES LONG-ACTING CONTRACEPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 181. UNITED ARAB EMIRATES LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 182. UNITED ARAB EMIRATES LONG-ACTING CONTRACEPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED ARAB EMIRATES LONG-ACTING CONTRACEPTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED KINGDOM LONG-ACTING CONTRACEPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED KINGDOM LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED KINGDOM LONG-ACTING CONTRACEPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM LONG-ACTING CONTRACEPTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 188. LONG-ACTING CONTRACEPTION MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 189. LONG-ACTING CONTRACEPTION MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 190. LONG-ACTING CONTRACEPTION MARKET LICENSE & PRICING